1. Home
  2. SRPT vs ADEA Comparison

SRPT vs ADEA Comparison

Compare SRPT & ADEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • ADEA
  • Stock Information
  • Founded
  • SRPT 1980
  • ADEA 1990
  • Country
  • SRPT United States
  • ADEA United States
  • Employees
  • SRPT N/A
  • ADEA N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • ADEA Computer Software: Prepackaged Software
  • Sector
  • SRPT Health Care
  • ADEA Technology
  • Exchange
  • SRPT Nasdaq
  • ADEA Nasdaq
  • Market Cap
  • SRPT 2.0B
  • ADEA 1.6B
  • IPO Year
  • SRPT 1997
  • ADEA N/A
  • Fundamental
  • Price
  • SRPT $18.46
  • ADEA $15.41
  • Analyst Decision
  • SRPT Hold
  • ADEA Strong Buy
  • Analyst Count
  • SRPT 30
  • ADEA 4
  • Target Price
  • SRPT $44.37
  • ADEA $19.50
  • AVG Volume (30 Days)
  • SRPT 9.6M
  • ADEA 496.5K
  • Earning Date
  • SRPT 08-06-2025
  • ADEA 08-05-2025
  • Dividend Yield
  • SRPT N/A
  • ADEA 1.30%
  • EPS Growth
  • SRPT N/A
  • ADEA 80.44
  • EPS
  • SRPT N/A
  • ADEA 0.74
  • Revenue
  • SRPT $2,481,531,000.00
  • ADEA $378,674,000.00
  • Revenue This Year
  • SRPT $9.41
  • ADEA $9.49
  • Revenue Next Year
  • SRPT N/A
  • ADEA $4.94
  • P/E Ratio
  • SRPT N/A
  • ADEA $20.74
  • Revenue Growth
  • SRPT 64.89
  • ADEA 5.47
  • 52 Week Low
  • SRPT $10.42
  • ADEA $10.59
  • 52 Week High
  • SRPT $138.81
  • ADEA $17.46
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 48.03
  • ADEA 60.12
  • Support Level
  • SRPT $17.95
  • ADEA $15.28
  • Resistance Level
  • SRPT $19.61
  • ADEA $15.73
  • Average True Range (ATR)
  • SRPT 1.20
  • ADEA 0.47
  • MACD
  • SRPT -0.06
  • ADEA -0.00
  • Stochastic Oscillator
  • SRPT 19.69
  • ADEA 73.55

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About ADEA Adeia Inc.

Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.

Share on Social Networks: